Biofrontera announced the appointment of George Jones as chief commercial officer, starting August 25. In this role, Jones will oversee the company’s commercial functions, including sales, marketing, and market access. He will report directly to CEO Hermann Luebbert.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFRI:
- Biofrontera, Inc. (BFRI) Q2 Earnings Cheat Sheet
- Biofrontera Inc. files to sell 13.6M shares of common stock for holders
- Biofrontera Finalizes Acquisition of U.S. Ameluz Rights
- Biofrontera Restructures U.S. Rights with $11M Investment
- Biofrontera Inc. price target raised to $10 from $8 at Roth Capital